Risk prediction rule for advanced neoplasia on screening colonoscopy for average-risk individuals

doi:10.3748/wjg.v26.i37.5705

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 37

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5942)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

329

WORD

128

HTML

2668

Figures (1-3)

243

Tables (1-3)

245

Sum=3613

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

693

Download

1636

Sum=2329

Oct 7, 2020 (publication date) through Jul 25, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastroenterol. Oct 7, 2020; 26(37): 5705-5717
Published online Oct 7, 2020. doi: 10.3748/wjg.v26.i37.5705

Table 1 Univariate analysis of clinical features and detection of advanced neoplasia

Characteristic	Total	Absence of AN	Presence of AN	P value
	n (%)	n (%)	n (%)
Age (mean ± SD)	980 (100)	61 ± 8	63 ± 9	0.242
Median, IQR		60, 12	63, 13
Male	479 (48.9)	448 (48.2)	31(62.0)	0.07
Smoking	460 (46.9)	425 (45.7)	35 (70.0)	0.01
Daily bowel movement	859 (87.7)	814 (87.6)	45 (90.0)	0.62
Caffeine	885 (90.3)	836 (89.9)	49 (98.0)	0.06
Exercise	544 (55.5)	52 (56.5)	19 (38.0)	0.01
Alcohol	491 (50.1)	468 (50.3)	23 (46.0)	0.55
Daily red meat consumption	90 (9.2)	81 (8.7)	9 (18.0)	0.03
Daily poultry consumption	39 (4.0)	37 (4.0)	2 (4.0)	0.99
Daily dairy consumption	744 (75.9)	703 (75.6)	41 (82.0)	0.30
Daily fruit/vegetable consumption	909 (92.8)	865 (93.0)	44 (88.0)	0.18
NSAID use	177 (18.1)	171 (18.4)	6 (12.0)	1.31
Aspirin use	312 (31.8)	294 (31.6)	18 (36.0)	0.42
Multi vitamin/antixoidant use	415 (42.3)	397 (42.7)	18 (36.0)	0.87
Oral contraceptive pills/hormone replacement therapy used	126 (12.9)	121 (13.0)	5 (10.0)	0.38
Calcium supplementation	429 (43.8)	413 (44.4)	16 (32.0)	0.30
Diabetes mellitus	80 (8.2)	74 (8.0)	6 (12.0)	1.04
Body Mass Index (BMI)				0.01
mean ± SD	980 (100)	26.7 ± 4.1	28.4 ± 3.3	0.01
Median, IQR		26.7, 5.1	28.5, 4.5
< 25^a	330 (33.7)	322 (34.6)	8 (16.0)
25-30	454 (46.3)	429 (46.1)	25 (50.0)
> 30^a	196 (20.0)	179 (19.2)	17 (34.0)
Pack years				< 0.01
mean ± SD	980 (100)	13 ± 21	29 ± 33	< 0.01
Median, IQR		0, 20	18, 40
≤ 10^a	520 (53.1)	505 (54.3)	15 (30.0)
11-40^a	331 (33.8)	311 (33.4)	20 (40.0)
> 40^a	129 (13.2)	114 (12.3)	15 (30.0)
Frequency of alcohol intake				0.8
None	489 (49.9)	462 (49.7)	27 (54.0)
< 1 drink daily	391 (39.9)	377 (40.5)	14 (28.0)
At least 1 drink daily	100 (10.2)	91 (9.8)	9 (18.0)
Daily alcohol consumption	100 (10.2)	91 (9.8)	9 (18.0)	0.06
Body surface area (mean ± SD)		1.8 ± 2.045	1.9 ± 0.02	0.02
Median, IQR		1.8, 0.28	1.9, 0.22

^aIndicates significance on post-hoc analysis (P < 0.05), AN: Advanced neoplasia.

Citation: Sharara AI, El Mokahal A, Harb AH, Khalaf N, Sarkis FS, M El-Halabi M, Mansour NM, Malli A, Habib R. Risk prediction rule for advanced neoplasia on screening colonoscopy for average-risk individuals. World J Gastroenterol 2020; 26(37): 5705-5717
URL: https://www.wjgnet.com/1007-9327/full/v26/i37/5705.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i37.5705